Endophthalmitis Prophylaxis Study, Report 2: Intracameral antibiotic prophylaxis with or without postoperative topical antibiotic in cataract surgery

Purpose: Intracameral antibiotic in cataract surgery has shown level I evidence as prophylaxis for postoperative endophthalmitis. Not much is known if one should also use topical antibiotics after intracameral injection. The purpose of the study was to determine efficacy of intracameral antibiotic with and without postoperative topical antibiotic in reducing the incidence of acute endophthalmitis after cataract surgery in rural India. Methods: A prospective comparative, non-randomized interventional study was designed in 15 rural centres in India. The study recruited 40,006 patients (n = 42,466 eyes), who underwent cataract surgery (phacoemulsification/small incision cataract surgery), and received intracameral antibiotic (cefuroxime/moxifloxacin). Postoperative topical antibiotic prescription was left to the choice of the treating physician, but they were encouraged not to use it in uneventful surgeries. Primary outcome measure was occurrence of acute clinical endophthalmitis within 6 weeks of surgery. Statistical analysis was done using STATA software v13.1 (StataCorp, Texas); P value of <0.05 was considered statistically significant. Results: In the study, 17,932 (42%) eyes received intracameral cefuroxime (ICC) and 24,534 (58%) eyes received intracameral moxifloxacin (ICM). Topical antibiotic was not prescribed to 17,855 (42%) eyes - 5723 (32%) eyes in ICC group and 12,132 (68%) eyes in ICM group. Acute clinical endophthalmitis occurred in 15 (0.035%) eyes - 1 / 3515 (0.028%) eyes and 1 / 2231 (0.045%) eyes that received and did not receive topical antibiotic, respectively. The difference in occurrence of endophthalmitis with/without topical antibiotics in each group (ICC: 0.016% and 0.017%; P = 0.958; ICM: 0.040% and 0.058%; P = 0.538) was not significant (P = 0.376). Conclusion: Supplementing intracameral antibiotic with topical antibiotic postoperatively did not impact the occurrence of acute post cataract surgery endophthalmitis in rural India

[1]  T. Das,et al.  Endophthalmitis prophylaxis study. Report 1: Intracameral cefuroxime and moxifloxacin prophylaxis for the prevention of postcataract endophthalmitis in rural India , 2020, Indian journal of ophthalmology.

[2]  T. Das,et al.  All India Ophthalmological Society members survey results: Cataract surgery antibiotic prophylaxis current practice pattern 2017 , 2018, Indian journal of ophthalmology.

[3]  D. Chang,et al.  Endophthalmitis Reduction with Intracameral Moxifloxacin Prophylaxis: Analysis of 600 000 Surgeries. , 2017, Ophthalmology.

[4]  M. Jabbarvand,et al.  Endophthalmitis Occurring after Cataract Surgery: Outcomes of More Than 480 000 Cataract Surgeries, Epidemiologic Features, and Risk Factors. , 2016, Ophthalmology.

[5]  B. Ambati,et al.  Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery , 2016, International Ophthalmology.

[6]  J. Hjortdal,et al.  Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta‐analysis , 2015, Acta ophthalmologica.

[7]  P. Barry.  Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: Update on the ESCRS Endophthalmitis Study , 2014, Journal of cataract and refractive surgery.

[8]  P. Camacho,et al.  Cohort Study of Intracameral Moxifloxacin in Postoperative Endophthalmitis Prophylaxis , 2014, Ophthalmology and eye diseases.

[9]  J. Vander,et al.  The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. , 2014, Ophthalmology.

[10]  P. Barry.  Intracameral antibiotic prophylaxis: American paper mirrors European experience. , 2013, Journal of cataract and refractive surgery.

[11]  H. Flynn,et al.  Acute Postoperative Endophthalmitis Following Cataract Surgery: A Review , 2012, Asia-Pacific journal of ophthalmology.

[12]  W. Stark,et al.  Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients , 2010, Journal of cataract and refractive surgery.

[13]  A. Duggirala,et al.  Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison. , 2007, Indian journal of ophthalmology.

[14]  G. Gettinby,et al.  ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study , 2006, Journal of cataract and refractive surgery.

[15]  S. Masket,et al.  Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. , 2002, Ophthalmology.

[16]  D. King,et al.  New classification and update on the quinolone antibiotics. , 2000, American family physician.

[17]  Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. , 1995, Archives of ophthalmology.

[18]  J. Menikoff,et al.  Prophylaxis of endophthalmitis with topical povidone-iodine. , 1991, Ophthalmology.